Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06119854 · ClinicalTrials.gov registry record · NA
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
A NA study, sponsored by City University of New York, School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 1,419
- Enrollment target
NCT06119854 is a NA study that has completed, run by City University of New York, School of Public Health. The registered enrollment target is 1,419 participants.
The verdict
NCT06119854, a NA study, has completed, sponsored by City University of New York, School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,419 participants
- Enrollment target
Study Summary
The COVID-19 pandemic has led to a mis/disinformation ecosystem that promotes divergent views of vaccine efficacy, as well as the legitimacy of science and medicine. Individuals are confronted with vaccine-related information from a multitude of sources, posing a challenge to identifying inaccurate information. COVID-19 vaccine uptake is lower among people with anxiety and depression than in the general population, due in part to higher levels of vaccine hesitancy. The prevalence of anxiety and depressive symptoms among US adults increased significantly during the COVID pandemic and has remained elevated. Interventions capable of mitigating the impact of vaccine hesitancy and mis/disinformation among undervaccinated people with anxiety or depression are therefore an urgent priority. Emerging evidence suggests that reasons for vaccine hesitancy and the impact of conventional vaccination messaging differ between those with and without mental health symptoms. There may also be added challenges overcoming logistical barriers to vaccination for people with anxiety or depressive symptoms. The investigators aim to determine the effectiveness of two different brief digital intervention strategies compared with conventional public health messaging for increasing vaccine uptake in undervaccinated adults with and without anxiety or depressive symptoms. Attitudinal inoculation is a brief, scalable strategy that leverages the power of narrative, values, and emotion to strengthen resistance to mis/disinformation and reduce hesitancy. Though this approach has been shown to decrease COVID-19 vaccine hesitancy among US adults, the extent to which this approach increases COVID-19 vaccination remains unknown. Cognitive-behavioral therapy (CBT) is an evidence-based intervention for anxiety and depression. However, the efficacy of incorporating CBT-informed messaging in a vaccine promotion intervention has not been tested. The investigators hypothesize that both attitudinal inoculation
Interventions
- BEHAVIORAL Attitudinal inoculation
- BEHAVIORAL Cognitive-behavioral therapy-informed intervention
- BEHAVIORAL Conventional public health messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,419 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2024-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06119854
The ClinicalTrials.gov registry entry for NCT06119854 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,419 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City University of New York, School of Public Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Attitudinal inoculation is the first listed.
NCT06119854 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06119854 about?
NCT06119854 is a clinical study titled "Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression". The COVID-19 pandemic has led to a mis/disinformation ecosystem that promotes divergent views of vaccine efficacy, as well as the legitimacy of science and medicine. Individuals are confronted with vaccine-related information from a multitude of sources, posing a challenge to identifying inaccurate ...
What is the current status of trial NCT06119854?
This trial is currently completed. It is a NA study. The enrollment target is 1,419 participants. The study started on 2024-04-15. Estimated completion is 2024-11-15.
What interventions are being tested in trial NCT06119854?
The interventions under investigation include: Attitudinal inoculation (BEHAVIORAL), Cognitive-behavioral therapy-informed intervention (BEHAVIORAL), Conventional public health messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06119854?
This trial is sponsored by City University of New York, School of Public Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.